U.S. Global Investors (USGI)’s Edwards Lifesciences EW Stock Holding History

U.S. Global Investors (USGI)’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-30,000	Closed	-$711K	–	266
2015 Q3	$711K	Hold	30,000	–	–	0.38%	74
2015 Q2	$712K	Hold	30,000	–	–	0.27%	91
2015 Q1	$712K	Buy	+30,000	New	+$673K	0.2%	113
2013 Q4	–	Sell	-54,300	Closed	-$630K	–	331
2013 Q3	$630K	Hold	54,300	–	–	0.11%	154
2013 Q2	$608K	Buy	+54,300	New	+$643K	0.1%	150

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

U.S. Global Investors (USGI)'s EW Position: Q4 2015 in Review

U.S. Global Investors (USGI) sold out of Edwards Lifesciences (EW) in Q4 2015, closing a stake of 30,000 shares — an estimated $711K sold.

U.S. Global Investors (USGI) first reported a position in EW in Q2 2013 and held it in 5 quarters. The position peaked at $712K in Q2 2015. 605 funds tracked by Wall St. Rank hold EW as of Q4 2015.

U.S. Global Investors (USGI) reported no remaining Edwards Lifesciences position as of Q4 2015 after selling out during the quarter.
U.S. Global Investors (USGI) sold 30,000 Edwards Lifesciences shares in Q4 2015, an estimated $711K.
U.S. Global Investors (USGI) first reported a position in Edwards Lifesciences in Q2 2013 and held it in 5 quarters.
U.S. Global Investors (USGI)'s Edwards Lifesciences position peaked at $712K in Q2 2015.
605 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2015.

Based on U.S. Global Investors (USGI)'s 13F filing for Q4 2015, filed 16 Feb 2016.